The panel includes not only well-characterized esophageal cancer-associated genes[52] (e.g., TP53, CDKN2A, PIK3CA, NOTCH1, KMT2D) but also other clinically relevant genes across multiple tumor types, ensuring broad coverage for Liquid biopsy applications. This evidence concerns the gene TP53 and esophageal cancer.